Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandra Rozlan

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Plos One|April 25, 2012
Altered thymic function during interferon therapy in HCV-infected patientsStephanie Beq, Sandra Rozlan, Sandy Pelletier, et al.
AIDS (London, England)|January 26, 2018
HIV reservoir dynamics in HAART-treated poor immunological responder patients under IL-7 therapySandrine Logerot, Magali Rancez, Bénédicte Charmeteau-de Muylder, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 19, 2012
Initiation of c-ART in HIV-1 infected patients is associated with a decrease of the metabolic activity of the thymus evaluated using FDG-PET/computed tomographyJean-Daniel Lelièvre, Giovanna Melica, Emmanuel Itti, et al.
Blood|April 9, 2009
Injection of glycosylated recombinant simian IL-7 provokes rapid and massive T-cell homing in rhesus macaquesStéphanie Beq, Sandra Rozlan, David Gautier, et al.
AIDS (London, England)|April 21, 2011
CD4⁺ recent thymic emigrants are infected by HIV in vivo, implication for pathogenesisVéronique Fabre-Mersseman, Jacques Dutrieux, Anne Louise, et al.
Blood|September 16, 2010
Interleukin-7 treatment counteracts IFN-α therapy-induced lymphopenia and stimulates SIV-specific cytotoxic T lymphocyte responses in SIV-infected rhesus macaquesRaphaëlle Parker, Jacques Dutrieux, Stéphanie Beq, et al.
AIDS (London, England)|March 12, 2014
Modified interferon-α subtypes production and chemokine networks in the thymus during acute simian immunodeficiency virus infection, impact on thymopoiesisJacques Dutrieux, Véronique Fabre-Mersseman, Bénédicte Charmeteau-De Muylder, et al.
Science Advances|August 30, 2024
Multi-armored allogeneic MUC1 CAR T cells enhance efficacy and safety in triple-negative breast cancerPiril Erler, Tomasz Kurcon, Hana Cho, et al.
Nature Communications|June 30, 2022
Endowing universal CAR T-cell with immune-evasive properties using TALEN-gene editingSumin Jo, Shipra Das, Alan Williams, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Plos One|April 25, 2012
Altered thymic function during interferon therapy in HCV-infected patientsStephanie Beq, Sandra Rozlan, Sandy Pelletier, et al.
AIDS (London, England)|January 26, 2018
HIV reservoir dynamics in HAART-treated poor immunological responder patients under IL-7 therapySandrine Logerot, Magali Rancez, Bénédicte Charmeteau-de Muylder, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 19, 2012
Initiation of c-ART in HIV-1 infected patients is associated with a decrease of the metabolic activity of the thymus evaluated using FDG-PET/computed tomographyJean-Daniel Lelièvre, Giovanna Melica, Emmanuel Itti, et al.
Blood|April 9, 2009
Injection of glycosylated recombinant simian IL-7 provokes rapid and massive T-cell homing in rhesus macaquesStéphanie Beq, Sandra Rozlan, David Gautier, et al.
AIDS (London, England)|April 21, 2011
CD4⁺ recent thymic emigrants are infected by HIV in vivo, implication for pathogenesisVéronique Fabre-Mersseman, Jacques Dutrieux, Anne Louise, et al.
Blood|September 16, 2010
Interleukin-7 treatment counteracts IFN-α therapy-induced lymphopenia and stimulates SIV-specific cytotoxic T lymphocyte responses in SIV-infected rhesus macaquesRaphaëlle Parker, Jacques Dutrieux, Stéphanie Beq, et al.
AIDS (London, England)|March 12, 2014
Modified interferon-α subtypes production and chemokine networks in the thymus during acute simian immunodeficiency virus infection, impact on thymopoiesisJacques Dutrieux, Véronique Fabre-Mersseman, Bénédicte Charmeteau-De Muylder, et al.
Science Advances|August 30, 2024
Multi-armored allogeneic MUC1 CAR T cells enhance efficacy and safety in triple-negative breast cancerPiril Erler, Tomasz Kurcon, Hana Cho, et al.
Nature Communications|June 30, 2022
Endowing universal CAR T-cell with immune-evasive properties using TALEN-gene editingSumin Jo, Shipra Das, Alan Williams, et al.
Pageof 1